About CombiMatrix
Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012.
In 2017, Invitae acquired Good Start Genetics and CombiMatrix. In 2020, Invitae announced the acquisition of ArcherDX for $1.4 billion. In 2021, Invitae announced the acquisition of health care AI startup Ciitizen for $325 million.
In early 2024, Invitae filed for Chapter 11 bankruptcy protection, and later announced an agreement for an acquisition by Labcorp.
From Wikipedia: read the full article · text available under CC BY-SA 4.0
More about CombiMatrix
- Acquisitions and changes
- No longer listed: ticker CBMX is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).
Market cap history
Not enough history yet.
Sources and freshness
- Profile updated:
- Nov 14, 2026
Figures from Wikidata, Wikipedia, Wikimedia Commons, value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at CombiMatrix? Verify and update this profile — free
Show CombiMatrix's ranking on your website Get the badge
The badge updates itself as the ranking changes.